Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.09 USD | -6.08% | -12.22% | +52.97% |
01:18pm | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
05-08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.97% | 300M | |
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+3.73% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.68% | 168B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Transcript : Aquestive Therapeutics, Inc., Q4 2023 Earnings Call, Mar 06, 2024